Drug Information| Drug ID:   | NPD1153 |
| Drug Name:   | |
| Molecular Formula:   | C13H26O6P2 |
| Canonical SMILES:   | C/C(=CCCCC(P(=O)(O)O)P(=O)(O)O)/CCC=C(C)C |
| Standard InCHI:   | "InChI=1S/C13H26O6P2/c1-11(2)7-6-9-12(3)8-4-5-10-13(20(14,15)16)21(17,18)19/h7-8,13H,4-6,9-10H2,1-3H3,(H2,14,15,16)(H2,17,18,19)/b12-8+" |
| Standard InCHIKey:   | ISMDHWZGHKZNRH-XYOKQWHBSA-N |
| Max Developmental Stage:   | Clinical (unspecified phase) |
| Max Developmental Stage Source:   | TTD |
  Structural Similarity Between NPASS Natural Products and NPD1153Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
  Similar Natural Products High Similarity: Tc>=0.85; Intermediate Similarity: 0.7 <= Tc < 0.85; Remote Similarity: 0.5 <= Tc < 0.7
| Similarity Level | Similarity Score | Natural Product ID |
|---|---|---|
| Remote Similarity | 0.5333 | NPC172421 |
| Remote Similarity | 0.5333 | NPC102486 |
| Remote Similarity | 0.5333 | NPC534474 |
| Remote Similarity | 0.5294 | NPC586979 |
| Molecular Weight   | 340.12 |
| ALogP   | 0.9722 |
| MLogP   | 2.01 |
| XLogP   | 1.202 |
| HDA   | 6 |
| HBD   | 4 |
| Rotatable Bonds   | 16 |
| TPSA   | 134.68 |
| RO5 Violation   | 0 |